Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOCRATES: Stelara for Chronic Antibiotic Refractory Pouchitis
2019-003151-11Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ustekinumab in pouchitis, sponsored by UZ Leuven. Primary endpoint: Steroid-free clinical remission at week 16. Started Jan 2020; status: completed.
02
Drugs
ustekinumab
03
Conditions
pouchitis
Beyond the preview
Go deeper on 2019-003151-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003151-11.